1 FEMALE ROMK NULL MICE MANIFEST MORE SEVERE BARTTER II PHENOTYPE ON RENAL FUNCTION AND HIGHER PGE 2 PRODUCTION
暂无分享,去创建一个
A. Cantone | G. Giebisch | S. Hebert | Tong Wang | Xinbo Yang | Q. Yan
[1] G. Burckhardt,et al. Gender differences in kidney function , 2007, Pflügers Archiv - European Journal of Physiology.
[2] D. Pearse,et al. Up-regulation of glomerular COX-2 by angiotensin II: role of reactive oxygen species. , 2005, Kidney international.
[3] S. Waldegger,et al. Salt handling in the distal nephron: lessons learned from inherited human disorders. , 2005, American journal of physiology. Regulatory, integrative and comparative physiology.
[4] J. Pollock,et al. Downloaded from http://hyper.ahajournals.org / by guest on February 21, 2013Sexual Dimorphism in Renal Production of Prostanoids in Spontaneously Hypertensive Rats , 2022 .
[5] I. Armando,et al. Estrogen upregulates renal angiotensin II AT1 and AT2 receptors in the rat , 2005, Regulatory Peptides.
[6] H. Seyberth,et al. The role of cyclooxygenases and prostanoid receptorsin furosemide-like salt losing tubulopathy: the hyperprostaglandin E syndrome. , 2004, Acta physiologica Scandinavica.
[7] V. Koch,et al. Bartter syndrome: benefits and side effects of long-term treatment , 2004, Pediatric Nephrology.
[8] G. Giebisch,et al. ROMK is required for expression of the 70-pS K channel in the thick ascending limb. , 2004, American journal of physiology. Renal physiology.
[9] W. Proesmans,et al. Growth from birth to adulthood in a patient with the neonatal form of bartter syndrome , 1988, Pediatric Nephrology.
[10] M. Imai,et al. Effects of prostaglandins on Na transport in isolated collecting tubules , 1978, Pflügers Archiv.
[11] J. Neugarten. Gender and the progression of renal disease. , 2002, Journal of the American Society of Nephrology : JASN.
[12] T. Doetschman,et al. Impaired Renal NaCl Absorption in Mice Lacking the ROMK Potassium Channel, a Model for Type II Bartter's Syndrome* , 2002, The Journal of Biological Chemistry.
[13] G. Giebisch,et al. Absence of Small Conductance K+ Channel (SK) Activity in Apical Membranes of Thick Ascending Limb and Cortical Collecting Duct in ROMK (Bartter's) Knockout Mice* , 2002, The Journal of Biological Chemistry.
[14] H. Seyberth,et al. Role of cyclooxygenase-2 in hyperprostaglandin E syndrome/antenatal Bartter syndrome. , 2002, Kidney international.
[15] M. Breyer,et al. Physiological regulation of cyclooxygenase-2 in the kidney. , 2001, American journal of physiology. Renal physiology.
[16] M. Breyer,et al. Cyclooxygenase-2-selective inhibitors impair glomerulogenesis and renal cortical development. , 2000, Kidney international.
[17] R. Kalb,et al. Defective fluid and HCO(3)(-) absorption in proximal tubule of neuronal nitric oxide synthase-knockout mice. , 2000, American journal of physiology. Renal physiology.
[18] P. Igarashi,et al. Uncompensated polyuria in a mouse model of Bartter's syndrome. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[19] D. E. Faunce,et al. Estrogen mediates the sex difference in post-burn immunosuppression. , 2000, The Journal of endocrinology.
[20] G. Giebisch,et al. Mechanism of proximal tubule bicarbonate absorption in NHE3 null mice. , 1999, The American journal of physiology.
[21] G. FitzGerald,et al. Effects of specific inhibition of cyclooxygenase-2 on sodium balance, hemodynamics, and vasoactive eicosanoids. , 1999, The Journal of pharmacology and experimental therapeutics.
[22] I. Ichikawa,et al. Angiotensin II attenuates renal cortical cyclooxygenase-2 expression. , 1999, The Journal of clinical investigation.
[23] G. Giebisch,et al. A tyrosine-based signal regulates H-K-ATPase-mediated potassium reabsorption in the kidney. , 1998, The American journal of physiology.
[24] M. Konrad,et al. A Hyperprostaglandin E Syndrome Mutation in Kir1.1 (Renal Outer Medullary Potassium) Channels Reveals a Crucial Residue for Channel Function in Kir1.3 Channels* , 1998, The Journal of Biological Chemistry.
[25] L. Bianchi,et al. Functional consequences of ROMK mutants linked to antenatal Bartter's syndrome and implications for treatment. , 1998, Human molecular genetics.
[26] H. Omran,et al. Two novel mutations of the gene for Kir 1.1 (ROMK) in neonatal Bartter syndrome , 1998, Pediatric Nephrology.
[27] G. Giebisch,et al. Renal K+ channels: structure and function. , 1997, Annual review of physiology.
[28] R. Carey,et al. The subtype 2 (AT2) angiotensin receptor mediates renal production of nitric oxide in conscious rats. , 1997, The Journal of clinical investigation.
[29] D. Kaji,et al. Prostaglandin E2 inhibits Na-K-2Cl cotransport in medullary thick ascending limb cells. , 1996, The American journal of physiology.
[30] J. Craig,et al. Indomethacin for renal impairment in neonatal Bartter's syndrome , 1996, The Lancet.
[31] T. Ogihara,et al. [Bartter syndrome]. , 2020, Nihon rinsho. Japanese journal of clinical medicine.
[32] S. Silbiger,et al. The impact of gender on the progression of chronic renal disease. , 1995, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[33] L. Peterson,et al. Endogenous prostaglandin E2 mediates inhibition of rat thick ascending limb Cl reabsorption in chronic hypercalcemia. , 1993, The Journal of clinical investigation.
[34] K. Kokko,et al. Inhibition of apical Na+ channels in rabbit cortical collecting tubules by basolateral prostaglandin E2 is modulated by protein kinase C. , 1992, The Journal of clinical investigation.
[35] H. Seyberth,et al. Increased Renal Biosynthesis of Prostaglandin E2 and Thromboxane B2 in Human Congenital Obstructive Uropathy , 1990, Pediatric Research.
[36] M. Zeidel,et al. Prostaglandin E2 inhibits Na+-K+-ATPase activity in the inner medullary collecting duct. , 1989, The American journal of physiology.
[37] R. Kunau,et al. Angiotensin II-stimulated prostaglandin production by canine renal afferent arterioles. , 1988, The American journal of physiology.
[38] A. Fujimura,et al. Role of angiotensin II in renal prostaglandin E2 production after furosemide administration. , 1988, Hypertension.
[39] N. Farman,et al. Segmental synthesis and actions of prostaglandins along the nephron. , 1987, The American journal of physiology.
[40] P. Klotman,et al. Thromboxane synthetase inhibition improves function of hydronephrotic rat kidneys. , 1986, The American journal of physiology.
[41] P. Needleman,et al. Renal arachidonic acid metabolism and cellular changes in the rabbit renal vein constricted kidney: inflammation as a common process in renal injury models. , 1984, Prostaglandins.
[42] C. Cerletti,et al. Correction of increased prostacyclin synthesis in Bartter's syndrome by indomethacin treatment. , 1980, Prostaglandins and medicine.
[43] J. Gill. Bartter's syndrome. , 1980, Annual review of medicine.
[44] A. Simopoulos. Growth characteristics in patients with Bartter's syndrome. , 1979, Nephron.
[45] J. Gill,et al. Hyperplasia of the Juxtaglomerular Complex with Hyperaldosteronism and Hypokalemic Alkalosis. , 1963 .